The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 107.60
Bid: 0.00
Ask: 130.00
Change: 0.00 (0.00%)
Spread: 22.60 (21.043%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 107.60
SAGA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Saga awarded industry-leading accreditation

27 Nov 2020 07:00

RNS Number : 6956G
SAGA PLC
27 November 2020
 

27 November 2020

Saga plc

("Saga" or "the Group")

Saga awarded first industry-leading COVID health accreditation

Saga has become the first cruise operator to be awarded new COVID-19 health assurance accreditation by Lloyd's Register, the maritime safety experts. The move is a crucial step ahead of the planned return of cruise operations in spring next year in a COVID-secure environment.

Lloyd's Register has awarded Saga the Shield+ accreditation, the highest category of health assurance they have. The new framework has been created to reduce risk and provide greater confidence in the safety procedures of operators against the introduction of infectious diseases onboard cruise ships, including COVID-19, Norovirus and common flu, as the industry works with government to restart an industry that employs 88,000 people and is worth £10bn a year to the British economy.

Being awarded the accreditation demonstrates that Saga exceeds the compliance criteria in every category set out by the UK Chamber of Shipping in their guidance for COVID Secure Cruising, which has been supported by the government.

The safety accreditation is assessed against six key categories covering every aspect of ship safety where health risks are elevated: medical, policy, food, ventilation, accommodation and water.

Award of the accreditation follows months of detailed planning from Saga, designing and putting in place detailed new procedures to meet the highest standards of health and safety. Saga's ships have been surveyed and inspected in all key areas and the accreditation has been awarded for both the Spirit of Discovery and the Spirit of Adventure, Saga's brand new ship, which is due to set sail for the first time in May 2021.

ENDS

For further information please contact:

Saga plc

Emily Roalfe, Head of Investor Relations Tel: 07732 093007

Email: Emily.roalfe@saga.co.uk

 

Headland

Susanna Voyle Tel: 020 3805 4822

Henry Wallers Email: saga@headlandconsultancy.com 

 

Notes to editors

About Saga

Saga is a specialist in the provision of products and services for life after 50. The Saga brand is one of the most recognised and trusted brands in the UK and is known for its high level of customer service and its high quality, award winning products and services including cruises and holidays, insurance, personal finance and publishing. www.saga.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKABDDBDBQDB
Date   Source Headline
17th Apr 20247:00 amRNSPreliminary Results
30th Jan 20247:00 amRNSTrading Update
26th Jan 20247:00 amRNSResponse to Media Coverage
15th Jan 20244:52 pmRNSHolding(s) in Company
21st Dec 20234:43 pmRNSHolding(s) in Company
21st Dec 20234:39 pmRNSDirector/PDMR Shareholding
21st Dec 20233:44 pmRNSDirectorate Change
8th Dec 202312:53 pmRNSHolding(s) in Company
28th Nov 20237:00 amRNSDirectorate Change
20th Nov 20234:00 pmRNSHolding(s) in Company
2nd Nov 20232:44 pmRNSDirector/PDMR Shareholding
17th Oct 202311:53 amRNSHolding(s) in Company
9th Oct 20237:00 amRNSDirectorate Change
27th Sep 20237:01 amRNSDirectorate Change
27th Sep 20237:00 amRNSInterim Results
9th Aug 20234:47 pmRNSDirector/PDMR Shareholding
9th Aug 20234:44 pmRNSTotal Voting Rights
1st Aug 20233:03 pmRNSIssue of Equity
26th Jul 20238:37 amRNSChange of Registered Office
22nd Jun 20232:38 pmRNSHolding(s) in Company
20th Jun 20233:53 pmRNSResults of 2023 Annual General Meeting
20th Jun 20237:00 amRNSAGM Trading Update
13th Jun 20235:00 pmRNSDirector/PDMR Shareholding
30th May 20232:19 pmRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSNotice of AGM
18th Apr 20237:00 amRNSAnnual Report and Accounts and Strategic Report
4th Apr 20237:00 amRNSPreliminary Results
2nd Mar 20239:10 amRNSTermination of discussions with Open Insurance
10th Feb 20237:00 amRNSResponse to Media Coverage
24th Jan 20237:01 amRNSCapital Markets Event
24th Jan 20237:00 amRNSTrading Update
23rd Jan 20237:00 amRNSResponse to Media Coverage
28th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20227:00 amRNSDirectorate Change
17th Nov 20222:47 pmRNSHolding(s) in Company
17th Nov 20229:00 amRNSEstablishment of New Committee
18th Oct 202210:15 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20227:00 amRNSInterim Results
23rd Aug 20227:00 amRNSDirectorate Change
18th Jul 20225:08 pmRNSDirector/PDMR Shareholding
8th Jul 202210:50 amRNSDirector/PDMR Shareholding
5th Jul 20224:19 pmRNSResult of 2022 AGM
5th Jul 20227:00 amRNSDirectorate Change
5th Jul 20227:00 amRNSTrading Update
30th May 20229:00 amRNSNotice of 2022 AGM
3rd May 20225:04 pmRNSDirector/PDMR Shareholding
31st Mar 20224:29 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.